Open AccessFibulin1 and mesothelin expressions in pancreas ductal adenocarcinoma
Author(s) -
Asude Aksoy
Publication year - 2023
Publication title -
i̇stanbul kuzey klinikleri
Language(s) - English
Resource type - Journals
ISSN - 2148-4902
DOI - 10.14744/nci.2022.49260
Subject(s) - mesothelin , medicine , pancreas , pancreatic ductal adenocarcinoma , immunohistochemistry , oncology , pancreatic cancer , gastroenterology , pathology , cancer
The balance between malignant tumor cells and the connective tissue surrounding them determines the aggressiveness of the tumor. We aimed to understand the effects of mesothelin (MSLN) and fibulin1 (FBLN1) expressions on survival in pancreas ductal adenocarcinoma (PDCA), and also whether these proteins have prognostic value for PDCA.